glp-1 mash Novo's Wegovy becomes first drug approved for mash and glp 1 GLP-1

& Roberts, C

For patients with a history of treated and stable malignancies, tesamorelin therapy should be initiated only after careful evaluation of the potential benefit of treatment relative to the risk of re-activation of the underlying malignancy

You wanted results not mental gymnastics

CJC-1295+ipamorelin works by binding to receptors in your pituitary gland, the small gland at the base of your brain that controls hormone production

However, emerging research suggests that these medications may offer unexpected benefits for brain health , including improvements in addiction, depression, and cognitive function